WQWenhui Qu

Wenhui Qu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Wenhui Qu has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Examining disease‐modifying roles of neurons in Alzheimer’s disease using a novel stem‐cell‐based human‐mouse chimeric transplantation model

    by Wenhui Qu, Matti Lam, Vilas Menon, Gunnar Hargus

    Background: Alzheimer’s disease (AD) and AD‐related dementias (ADRD) are fatal neurodegenerative diseases that impair the cognitive function of more than 40 million people worldwide without effective treatments. Despite the high prevalence of AD and ADRD, molecular mechanisms of neurodegeneration are only partially understood. Emerging evidence supports the physiological relevance of using induced pluripotent stem cell (iPSC) to model AD and related dementias. This study is set to determine neuron‐autonomous changes in AD iPSC‐derived neurons in vitro and in vivo.Method: In vivo and in vitro characterization of iPSCs. We have differentiated human iPSC‐derived neural cells carrying the familial AD V717I (London) mutation in the amyloid precursor protein (APPV717I) into mature neurons in vitro and employed Seahorse assay, whole transcriptomic profiling, mass spectrometry for 150 key metabolites of the intermediary metabolism, immunostainings, and biochemical assays. We have also transplanted human AD iPSC‐derived neural cells into the brains of adult immunocompromised mice. We then microdissected human grafts and employed single nucleus RNA sequencing (snRNA‐seq) to better understand the transcriptomic changes in transplanted cells at single‐cell resolution. We will then compare the transcriptomic data of the graft with preliminary or published snRNA‐seq data on post‐mortem brain tissue from AD patients.Result: we have also observed reduced baseline respiration in APPV717I neurons compared with their isogenic controls. Alterations of metabolic pathways were also observed in AD neurons, both in the pathway analysis of whole transcriptome profiles and in metabolomics studies. To further explore the molecular changes of iPSC‐derived AD neurons and to confirm key findings, AD or control neural cells were transplanted into the brains of immunocompromised mice and they showed robust survival and differentiation into neurons. snRNA‐seq on microdissected grafts is underway to better understand the transcriptomic changes in transplanted cells at single‐cell resolution.Conclusion: Preliminary results show cell‐autonomous changes of AD iPSC‐derived neurons in vitro and successful transplantation of human iPSC‐derived AD neural cells in vivo suggest the feasibility of modeling AD using this innovative in vivo human stem cell model.

  • Deletion of Small GTPase H-Ras Rescues Memory Deficits and Reduces Amyloid Plaque-Associated Dendritic Spine Loss in Transgenic Alzheimer’s Mice

    by Wenhui Qu, Angela Jeong, Rui Zhong, Josslen S. Thieschafer, Andrea Gram, Ling Li

    Alzheimer’s disease (AD) is a fatal neurodegenerative disorder, affecting millions of lives without a cure. While the molecular mechanism of AD remains obscure, emerging evidence suggests that small GTPases, a group of GTP-binding proteins that regulate a plethora of essential cellular events, modulate the pathogenic process of AD. Among those, the small GTPase H-Ras, extensively studied in cancer, regulates synaptic function, and both upstream and downstream signaling pathways of H-Ras have been implicated in AD. However, the role of H-Ras per se in AD pathogenesis had not been explored previously. In the present study, the impact of Hras deletion on cognitive function and amyloid pathology was investigated in transgenic APP/PS1 mice of AD. Behavioral assessments showed that the absence of Hras rescued spatial memory deficit in APP/PS1 mice at 9 months of age. The pathological evaluation demonstrated that Hras deletion reduced cortical amyloid deposition and astrogliosis. Furthermore, Hras deficiency protected against amyloid plaque-associated loss of dendritic spines in APP/PS1 mice. Intriguingly, canonical signaling pathways downstream of H-Ras were not affected by the absence of Hras in the brain. Unbiased transcriptomic analysis revealed that lack of H-Ras affected the expression of select genes in the brain of AD mice and identified a novel connection between H-Ras and Annexin A4, a calcium-dependent phospholipid-binding protein that has been shown to regulate membrane repair, neuroinflammation, and calcium homeostasis. Taken together, these data indicate that H-Ras modifies the pathogenic process of AD and may serve as a potential therapeutic target for AD.


  • Open Access

    Metabolic labeling with an alkyne probe reveals similarities and differences in the prenylomes of several brain-derived cell lines and primary cells

    by Kiall F. Suazo, Angela Jeong, Mina Ahmadi, Caroline Brown, Wenhui Qu, Ling Li, Mark D. Distefano

    Protein prenylation involves the attachment of one or two isoprenoid group(s) onto cysteine residues positioned near the C-terminus. This modification is essential for many signal transduction processes. In this work, the use of the probe C15AlkOPP for metabolic labeling and identification of prenylated proteins in a variety of cell lines and primary cells is explored. Using a single isoprenoid analogue, 78 prenylated protein groups from the three classes of prenylation substrates were identified including three novel prenylation substrates in a single experiment. Applying this method to three brain-related cell lines including neurons, microglia, and astrocytes showed substantial overlap (25%) in the prenylated proteins identified. In addition, some unique prenylated proteins were identified in each type. Eight proteins were observed exclusively in neurons, five were observed exclusively in astrocytes and three were observed exclusively in microglia, suggesting their unique roles in these cells. Furthermore, inhibition of farnesylation in primary astrocytes revealed the differential responses of farnesylated proteins to an FTI. Importantly, these results provide a list of 19 prenylated proteins common to all the cell lines studied here that can be monitored using the C15AlkOPP probe as well as a number of proteins that were observed in only certain cell lines. Taken together, these results suggest that this chemical proteomic approach should be useful in monitoring the levels and exploring the underlying role(s) of prenylated proteins in various diseases.


  • Neuronal Protein Farnesylation Regulates Hippocampal Synaptic Plasticity and Cognitive Function

    by Wenhui Qu, Kiall F. Suazo, Wenfeng Liu, Shaowu Cheng, Angela Jeong, David Hottman, Li-Lian Yuan, Mark D. Distefano, Ling Li

    Protein prenylation is a post-translational lipid modification that governs a variety of important cellular signaling pathways, including those regulating synaptic functions and cognition in the nervous system. Two enzymes, farnesyltransferase (FT) and geranylgeranyltransferase type I (GGT), are essential for the prenylation process. Genetic reduction of FT or GGT ameliorates neuropathology but only FT haplodeficiency rescues cognitive function in transgenic mice of Alzheimer’s disease. A follow-up study showed that systemic or forebrain neuron-specific deficiency of GGT leads to synaptic and cognitive deficits under physiological conditions. Whether FT plays different roles in shaping neuronal functions and cognition remains elusive. This study shows that in contrast to the detrimental effects of GGT reduction, systemic haplodeficiency of FT has little to no impact on hippocampal synaptic plasticity and cognition. However, forebrain neuron-specific FT deletion also leads to reduced synaptic plasticity, memory retention, and hippocampal dendritic spine density. Furthermore, a novel prenylomic analysis identifies distinct pools of prenylated proteins that are affected in the brain of forebrain neuron-specific FT and GGT knockout mice, respectively. Taken together, this study uncovers that physiological levels of FT and GGT in neurons are essential for normal synaptic/cognitive functions and that the prenylation status of specific signaling molecules regulates neuronal functions.


  • Open Access

    Atorvastatin enhances neurite outgrowth in cortical neurons in vitro via up-regulating the Akt/mTOR and Akt/GSK-3β signaling pathways

    by Hai-Juan Sui, Yan Dong, Qi Ding, Wen-Hui Qu, Sheng-Xue Yu, Ying-Xin Jin

    Aim: Methods: Results: Conclusion: